-
Food
-
Dietary Supplement Alerts and Safety Information
Alerts
- Aristolochic Acid
- Comfrey
- Ephedrine Alkaloids
- see Consolidated Information on Ephedrine Alkaloids*
- Kava
- Hepatic Toxicity Possibly Associated with Kava-Containing Products (CDC MMWR Report, November 29, 2002)
- Consumer Advisory: Kava-Containing Dietary Supplements May be Associated With Severe Liver Injury March 25, 2002
- Letter to Health Care Professionals: FDA Issues Consumer Advisory That Kava Products May be Associated with Severe Liver Injury* March 25, 2002
- Letter to Health Care Professionals about FDA Seeking Information on Liver Injury and Kava products* December 19, 2001
- LipoKinetix: FDA Warns About Weight Loss Product
FDA alerts consumers and health care professionals about LipoKinetix, a dietary supplement weight loss product. This product has been implicated in a number of serious adverse reactions related to several cases of liver injury.- FDA Warns Consumers Not to Use the Dietary Supplement LipoKinetix* November 19, 2001
- Letter to Health Care Professionals on Hazardous Dietary Supplement LipoKinetix* November 19, 2001
- Letter to Distributor on Hazardous Dietary Supplement LipoKinetix* November 19, 2001
- Liqiang 4
- FDA Issues Nationwide Alert for "Liqiang 4" Due to Potential Health Risk* July 1, 2005
- PC SPES and SPES
- MedWatch Safety Alert: Consumers Warned to Stop Using the Dietary Supplement/Herbal Products PC SPES and SPES* February 8, 2002
- Red Yeast Rice
- St. John's Wort and Indinavir
- Tiractricol
- FDA Warns Consumers Against Consuming Dietary Supplements Containing Tiractricol* November 21, 2000
- Triax Metabolic Accelerator
- FDA Warns Against Consuming Triax Metabolic Accelerator* November 11, 1999
- Other FDA Alerts
- FDA Warns Consumers Not to Feed Infants "Better than Formula Ultra Infant Immune Booster 117" January 23, 2004
- FDA Warns Public About Chinese Diet Pills Containing Fenfluramine* August 13, 2002
- FDA Recalls and Safety Alerts
- FDA Import Alerts and Import Detention Reports
Botanical Dietary Supplements
- Concerns About Botanicals and Other Novel Ingredients in Conventional Foods
- Letter to Health Professionals Regarding Safety Concerns Related to the Use of Botanical Products Containing Aristolochic Acid
- Adverse Events with Ephedra and Other Botanical Dietary Supplements
- FDA Advises Dietary Supplement Manufacturers to Remove Comfrey Products From the Market
Additional Safety Information
- Products Consumers Inquire About*:
Ephedra or Ephedrine; DHEA (dehydroepiandrosterone); Melatonin; Dieter's Teas; L-Tryptophan; Folic Acid; Gamma Hydroxybutyric Acid (GHB); Gamma Butyrolactone (GBL); and 1,4 Butanediol (BD) - MedWatch New Safety Information Summaries*:
2002 / 2001 / 2000 / 1999 / 1998 / 1997 - Archived Information: FDA Warning Statements Issued from 1993 to 2000*
- Buying Medicines and Medical Products Online*
- Other Sources of Safety Information* (such as NIH, USDA, etc.)
- Letter to Stakeholders Regarding Contract on Dietary Supplement Safety Issues* December 15, 2000
Reporting Problems
*Document is temporarily unavailable online.
Contact Us
- 1-888-SAFEFOOD
- 1-888-723-3366
Outreach and Information Center (HFS-009)
Consumers:
consumer@fda.govIndustry:
industry@fda.govCenter for Food Safety and Applied Nutrition
Food and Drug Administration
5100 Paint Branch Parkway
College Park, MD 20740
-
-
-